Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.
Get up to 30% off detailed market research reports-for a limited time only! The cerebrospinal fluid (CSF) cell counter market size is expected to see strong growth in the next few years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback